NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.210
+0.120 (11.01%)
Dec 5, 2025, 4:00 PM EST - Market closed
NovaBay Pharmaceuticals Market Cap
NovaBay Pharmaceuticals has a market cap or net worth of $152.47 million as of December 5, 2025. Its market cap has increased by 4,384.50% in one year.
Market Cap
152.47M
Enterprise Value
151.13M
1-Year Change
4,384.50%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since October 26, 2007, NovaBay Pharmaceuticals's market cap has increased from $76.50M to $152.47M, an increase of 99.31%. That is a compound annual growth rate of 3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 152.50M | 5,158.62% |
| Dec 31, 2024 | 2.90M | 123.08% |
| Dec 29, 2023 | 1.30M | -63.89% |
| Dec 30, 2022 | 3.60M | -78.70% |
| Dec 31, 2021 | 16.90M | -41.92% |
| Dec 31, 2020 | 29.10M | 62.57% |
| Dec 31, 2019 | 17.90M | 35.61% |
| Dec 31, 2018 | 13.20M | -77.70% |
| Dec 29, 2017 | 59.20M | 18.64% |
| Dec 30, 2016 | 49.90M | 612.86% |
| Dec 31, 2015 | 7.00M | -78.46% |
| Dec 31, 2014 | 32.50M | -32.85% |
| Dec 31, 2013 | 48.40M | 43.62% |
| Dec 31, 2012 | 33.70M | -11.32% |
| Dec 30, 2011 | 38.00M | -1.81% |
| Dec 31, 2010 | 38.70M | -19.21% |
| Dec 31, 2009 | 47.90M | 118.72% |
| Dec 31, 2008 | 21.90M | -72.59% |
| Dec 31, 2007 | 79.90M | 4.44% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |